Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Anthem Biosciences, headquartered in Indiana, is a prominent player in the medical, precision, and optical instruments sector. Founded in 2004, the company has established itself as a leader in providing innovative solutions for the biotechnology and pharmaceutical industries. With a focus on high-quality custom antibody production, protein expression, and assay development, Anthem Biosciences stands out for its commitment to precision and reliability.
The company operates primarily in the United States, serving a diverse clientele that includes research institutions and biopharmaceutical companies. Anthem Biosciences has achieved significant milestones, including the development of proprietary technologies that enhance the efficiency of its core services. Renowned for its exceptional quality and customer-centric approach, Anthem Biosciences continues to solidify its market position as a trusted partner in advancing scientific research and therapeutic development.
-15 vs industry average
Anthem Biosciences’s score of 17 is lower than 27% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Scope 3 accounts for ••• of total emissions.
Anthem Biosciences, headquartered in India and operating in the Medical, precision and optical instruments, watches and clocks industry, reported Scope 1 emissions of approximately 17,596,370 kg CO2e and Scope 2 emissions of about 2,338,520 kg CO2e for 2026. This totals approximately 19,935,000 kg CO2e for Scope 1 and 2 emissions combined.
In 2024, the company's Scope 1 emissions were approximately 13,561,000 kg CO2e, and Scope 2 emissions were about 3,923,000 kg CO2e, leading to a combined total of around 17,631,000 kg CO2e for Scope 1 and 2. For 2023, Anthem Biosciences reported Scope 1 emissions of approximately 10,798,000 kg CO2e and Scope 2 emissions of about 2,355,000 kg CO2e, summing to approximately 12,650,000 kg CO2e for Scope 1 and 2. Scope 3 emissions data was not disclosed for these periods.
Anthem Biosciences Limited has a "Committed" near-term target status with the Science Based Targets initiative (SBTi), as of January 2024. While specific target years or classifications are not provided for these commitments, the company has shown consistent disclosure of its Scope 1 and Scope 2 emissions. Some commitments under the name "Anthem Biosciences Limited" have an "Expired commitment" status as of May 2026. The SBTi commitments are directly attributed to Anthem Biosciences Limited, indicating no cascading from a parent organisation.
No climate goals have been disclosed for Anthem Biosciences yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Anthem Biosciences’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more